Pharmacokinetics and tolerability of atomoxetine in adults of known CYP2D6 phenotype.

被引：0
|
作者：
Witcher, J [1 ]
Long, A [1 ]
Sauer, JM [1 ]
Smith, B [1 ]
Read, H [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.11.103
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P27 / P27
页数：1
相关论文
共 50 条
  • [1] Effects of the CYP2D6 genotypes on the pharmacokinetics of atomoxetine
    Choi, Chang-Ik
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    FASEB JOURNAL, 2011, 25
  • [2] Pharmacokinetics of atomoxetine and effect of CYP2D6*10/*10 genotype in Japanese adults.
    Witcher, J. W.
    Long, A.
    Sauer, J.
    Smith, B. P.
    DeSante, K. A.
    Matsui, A.
    Takahashi, M.
    Nakano, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S64 - S64
  • [3] EFFECT OF PAROXETINE ON THE PHARMACOKINETICS OF ATOMOXETINE IN DIFFERENT CYP2D6 GENOTYPE
    Kim, S. H.
    Byeon, J. Y.
    Kim, Y. H.
    Lee, H. J.
    Lee, Y.
    Lee, Y. J.
    Kim, D. H.
    Lim, H. J.
    Lee, S. Y.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E60 - E60
  • [4] Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics
    Belle, DJ
    Ernest, CS
    Sauer, JM
    Smith, BR
    Thomasson, HR
    Witcher, JW
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1219 - 1227
  • [5] Pharmacokinetics, Safety, and Tolerability of Atomoxetine and Effect of CYP2D6*10/*10 Genotype in Healthy Japanese Men
    Matsui, A.
    Azuma, J.
    Witcher, J. W.
    Long, A. J.
    Sauer, J. -M.
    Smith, B. P.
    DeSante, K. A.
    Read, H. A.
    Takahashi, M.
    Nakano, M.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (03): : 388 - 403
  • [6] Mexiletine (MEX) as a probe drug to determine CYP2D6 phenotype.
    Labbe, L
    Hamelin, BA
    Fiset, C
    Lefez, C
    OHara, G
    Gilbert, M
    Turgeon, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIV28 - PIV28
  • [7] Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Na, Han-Sung
    Jang, Jong-Hwa
    Kim, Se-Hyung
    Lee, Yun-Jeong
    Bae, Jung-Woo
    Kim, In Su
    Jang, Choon-Gon
    Chung, Myeon-Woo
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (11) : 2083 - 2091
  • [8] Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
    Ji-Yeong Byeon
    Young-Hoon Kim
    Han-Sung Na
    Jong-Hwa Jang
    Se-Hyung Kim
    Yun-Jeong Lee
    Jung-Woo Bae
    In Su Kim
    Choon-Gon Jang
    Myeon-Woo Chung
    Seok-Yong Lee
    Archives of Pharmacal Research, 2015, 38 : 2083 - 2091
  • [9] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [10] EFFECTS OF CYP2D6*10/*10 GENOTYPE ON THE PHARMACOKINETICS OF ATOMOXETINE AND ITS METABOLITES
    Park, J., I
    Choi, C., I
    Bae, J. W.
    Jang, C. G.
    Lee, S. Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 65 - 65
12345